|
17 Sep 2025 |
CCL Products
|
Consensus Share Price Target
|
914.40 |
951.78 |
- |
4.09 |
buy
|
|
|
|
|
08 Nov 2023
|
CCL Products
|
BP Wealth
|
914.40
|
|
635.85
(43.81%)
|
|
Results Update
|
|
|
|
|
08 Nov 2023
|
CCL Products
|
Axis Direct
|
914.40
|
700.00
|
635.85
(43.81%)
|
Target met |
Buy
|
|
|
With an 12% upside from the CMP we maintain our BUY rating on the stock.
|
|
07 Nov 2023
|
CCL Products
|
IDBI Capital
|
914.40
|
707.00
|
625.25
(46.25%)
|
Target met |
Hold
|
|
|
|
|
18 Jul 2023
|
CCL Products
|
StoxBox - BP Wealth
|
914.40
|
|
620.55
(47.35%)
|
|
Buy
|
|
|
CCL Products (India) Ltd. (CCLP) registered a 28.6% YoY revenue growth to Rs. 654.9 crores in Q1FY24, surpassing market expectations of Rs. 580.1 crores, led by the company maintaining its volume-driven growth trajectory in the 18-20% range with additional volumes driven by the Vietnam plant.
|
|
18 Jul 2023
|
CCL Products
|
Axis Direct
|
914.40
|
750.00
|
620.55
(47.35%)
|
|
Buy
|
|
|
We have maintained a BUY on the stock with an unchanged TP of Rs 750/share as we roll over our estimates to Jun'25.
|
|
18 Jul 2023
|
CCL Products
|
IDBI Capital
|
914.40
|
822.00
|
620.55
(47.35%)
|
|
Buy
|
|
|
|
|
18 May 2023
|
CCL Products
|
Axis Direct
|
914.40
|
750.00
|
609.45
(50.04%)
|
|
Buy
|
|
|
Recommendation With a 23% upside from the CMP and the stock providing reasonable valuation and upside potential, we maintain our BUY rating on the stock.
|
|
18 May 2023
|
CCL Products
|
IDBI Capital
|
914.40
|
759.00
|
609.45
(50.04%)
|
|
Buy
|
|
|
|
|
13 Apr 2023
|
CCL Products
|
CD Equisearch
|
914.40
|
597.00
|
560.50
(63.14%)
|
Target met |
Hold
|
|
|
|
|
19 Jan 2023
|
CCL Products
|
Axis Direct
|
914.40
|
650.00
|
521.00
(75.51%)
|
Target met |
Buy
|
|
|
We maintain a BUY on the stock (Unchanged from the earlier stance). We increased our FY23/24E PAT estimates by 11%/4% to factor in lower tax guidance.
|